Elhízás: vizsgálatok itt: Csehország
36 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- České Budějovice, Náchod, Plzeň 3, Prague, Prague 4, Praha 2
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Brandýs nad Labem, Jesenice, Prague, Prague 6, Praha, Praha 6
- Életkor
- 18 év and over
- People
- 1600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - 3. fázisTaking peopleA Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Where
- Brno, České Budějovice, Habry, Moravska Ostrava A Privoz, Prague, Praha 9, Uherské Hradiště
- Életkor
- 18 év and over
- People
- 2001 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07794579 · EU 2026-526175-35-00 - 3. fázisTaking peopleA Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes
- Where
- Brandýs nad Labem, Brno-Stred, Lazce, Náchod, Ostrava, Prague
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07843485 · EU 2026-526189-25-00 - 3. fázisTaking peopleMirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Where
- Brno, Hradec Králové, Ostrava, Prague, Ústí nad Labem
- Életkor
- 18 év to 70 év
- People
- 350 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00 - 3. fázisTaking peopleMirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Where
- Brno, Hradec Králové, Ostrava, Prague, Ústí nad Labem
- Életkor
- 18 év to 70 év
- People
- 290 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00 - No phaseTaking peopleNational Childhood Obesity Prevention Programme BE FIT 24
- Where
- Prague
- Életkor
- 6 év to 11 év
- People
- 1000
- Run by
- Institute of Health Information and Statistics of the Czech Republic
See details and how to joinNCT07057453 - No phaseTaking peopleSafety and Effectiveness of Orbera365™ Intragastric Balloon System
- Where
- Prague
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Boston Scientific Corporation
See details and how to joinNCT07062094 - 3. fázisTaking peopleA Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
- Where
- Benešov, Brno, Karlovy Vary, Náchod, Olomouc, Ostrava, Pilsen, Prague
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07202884 · EU 2025-522514-23-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Where
- Krnov, Ostrava, Prague 1, Praha 1
- Életkor
- 18 év and over
- People
- 1035 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00 - 3. fázisTaking peopleEfficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Where
- Brno-Sever, Brno-Stred, Ostrava, Pardubice I, Uherské Hradiště
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07353931 · EU 2025-523768-19-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Where
- Holešov, Prague, Prague 8, Praha 4
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00 - 3. fázisNot yet taking people in CsehországA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- Náchod, Nový Jičín, Prague, Roudnice Nad Labem, Usti Nad Labem
- Életkor
- 45 év to 64 év
- People
- 3000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00 - 3. fázisTaking peopleMaridebart Cafraglutide versus Placebo in Adult Participants with Obstructive Sleep Apnea not on Positive Airway Pressure Therapy (MARITIME-OSA-2)
- Where
- Benesov, Brno, Moravska Ostrava A Privoz
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Amgen Inc.
See details and how to join2025-522699-94-00 · EU 2025-522699-94-00 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Where
- Benešov, Brno-Stred, Hodonín, Kladno, Moravska Ostrava A Privoz, Prague, Prague 10, Prague 14, Sedlcany, Steti, Votice
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00 - 3. fázisTaking peopleEfficacy and Safety of Once-Daily Oral ASC30 Compared with Placebo in Participants with Obesity or Overweight with Weight-Related Comorbidities
- Where
- Pardubice, Praha 2, Praha 5, Uherské Hradiště
- Életkor
- 18 év and over
- People
- 932 worldwide
- Run by
- Ascletis Pharma (China) Co. Ltd.
See details and how to join2026-526172-23-00 · EU 2026-526172-23-00 - 3. fázisTaking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Brandýs nad Labem, Brno, Broumov, Bruntál, Chlumec nad Cidlinou, Chomutov, Havirov - Mesto, Holešov, Hradec Králové, Jaroměř, Liberec, Mělník, Náchod, Olomouc, Ostrava, Pardubice, Prague, Praha 5 - Smichov, Přerov, Prostějov, Slaný, Trutnov, Uherské Hradiště, Ústí nad Labem
- Életkor
- 18 év to 99 év
- People
- 5056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459 - 3. fázisTaking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
- Where
- Brandýs nad Labem, Brno, Brno-Královo Pole, Brno-Stred, Brno-Zidenice, Broumov, Bruntal, Chlumec nad Cidlinou, Chomutov, Havířov, Holesov, Horni Brana, Horni Predmesti, Hradec Králové, Jaroměř, Liberec, Melnik, Moravska Ostrava A Privoz, Náchod, Olomouc, Ostrava, Pardubice, Pardubice I, Prague, Prague 1, Prague 2, Prerov I-Mesto, Prostějov, Slaný, Uherske Hradiste, Uherské Hradiště, Usti nad Labem, Ústí nad Labem, Valasske Mezirici
- Életkor
- 18 év and over
- People
- 2787 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-516654-22-00 · EU 2024-516654-22-00 - 3. fázisTaking peopleEfficacy and Safety of Once-Daily Oral ASC30 Compared with Placebo in Participants with Obesity or Overweight with Type 2 Diabetes Mellitus
- Where
- Pardubice, Praha 2, Praha 5, Uherské Hradiště
- Életkor
- 18 év and over
- People
- 549 worldwide
- Run by
- Ascletis Pharma (China) Co. Ltd.
See details and how to join2026-526336-39-00 · EU 2026-526336-39-00 - No phaseNot yet taking people in CsehországExercise Snacks Enabled by an mHealth Intervention Delivered in General Practice to Promote a Sustainable Active Lifestyle in Adults With Obesity
- Where
- Ostrava, Prague
- Életkor
- 18 év to 65 év
- People
- 306
- Run by
- Charles University, Czech Republic
See details and how to joinNCT07867665 - 3. fázisNot yet taking people in CsehországA Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
- Where
- Brandýs nad Labem, Brno, Broumov, České Budějovice, Chlumec Nad Cidlinou Iv, Chrudim IV, Hodonín, Horni Predmesti, Humpolec, Konska, Louny, Mariánské Lázně, Olomouc, Prague, Prague 13, Prague 2, Prague 8, Praha, Přerov, Prerov I-Mesto, Prostějov, Říčany, Slaný, Smiřice, Uherské Hradiště, Zlín
- Életkor
- 45 év to 64 év
- People
- 8500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07861100 · EU 2026-525182-53-00 - 3. fázisTaking peopleMaridebart Cafraglutide versus Placebo in Adult Participants with Obstructive Sleep Apnea on Positive Airway Pressure Therapy (MARITIME-OSA-1)
- Where
- Benesov, Brno, Moravska Ostrava A Privoz
- Életkor
- 18 év and over
- People
- 115 worldwide
- Run by
- Amgen Inc.
See details and how to join2025-522703-14-00 · EU 2025-522703-14-00 - 3. fázisTaking peopleA Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Where
- Brno-Stred, Dolní Břežany, Liberec, Náchod, Plzeň 3, Prague, Praha 22
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00 - 3. fázisTaking peopleA Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- Where
- Pardubice, Prague, Uherské Hradiště
- Életkor
- 18 év and over
- People
- 1560 worldwide
- Run by
- Ascletis Pharma (China) Co., Limited
See details and how to joinNCT07743450 - 3. fázisTaking peopleA Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- Where
- Pardubice, Prague, Uherské Hradiště
- Életkor
- 18 év and over
- People
- 3003 worldwide
- Run by
- Ascletis Pharma (China) Co., Limited
See details and how to joinNCT07743463